» Articles » PMID: 35010076

Interaction of Graphene Oxide Modified with Linear and Branched PEG with Monocytes Isolated from Human Blood

Overview
Date 2022 Jan 11
PMID 35010076
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple graphene-based therapeutics have recently been developed, however potential risks related to the interaction between nanomaterials and immune cells are still poorly understood. Therefore, studying the impact of graphene oxide on various populations of immune cells is of importance. In this work, we aimed to investigate the effects of PEGylated graphene oxide on monocytes isolated from human peripheral blood. Graphene oxide nanoparticles with lateral sizes of 100-200 nm and 1-5 μm were modified with linear and branched PEG (GO-PEG). Size, elemental composition, and structure of the resulting nanoparticles were characterized. We confirmed that PEG was successfully attached to the graphene oxide surface. The influence of GO-PEG on the production of reactive oxygen species (ROS), cytokines, phagocytosis, and viability of monocytes was studied. Uptake of GO-PEG by monocytes depends on PEG structure (linear or branched). Branched PEG decreased the number of GO-PEG nanoparticles per monocyte. The viability of monocytes was not altered by co-cultivation with GO-PEG. GO-PEG decreased the phagocytosis of Escherichia coli in a concentration-dependent manner. ROS formation by monocytes was determined by measuring luminol-, lucigenin-, and dichlorodihydrofluorescein-dependent luminescence. GO-PEG decreased luminescent signal probably due to inactivation of ROS, such as hydroxyl and superoxide radicals. Some types of GO-PEG stimulated secretion of IL-10 by monocytes, but this effect did not correlate with their size or PEG structure.

Citing Articles

Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line.

Angelopoulou A, Papachristodoulou M, Voulgari E, Mouikis A, Zygouri P, Gournis D Pharmaceutics. 2024; 16(11).

PMID: 39598575 PMC: 11597291. DOI: 10.3390/pharmaceutics16111452.


Conductive extracellular matrix derived/chitosan methacrylate/ graphene oxide-pegylated hybrid hydrogel for cell expansion.

Jaramillo V, Arevalo D, Gonzalez-Hernandez M, Cortes M, Perdomo-Arciniegas A, Cruz J Front Bioeng Biotechnol. 2024; 12:1398052.

PMID: 38952668 PMC: 11215370. DOI: 10.3389/fbioe.2024.1398052.


Interaction of Graphene Oxide Nanoparticles with Human Mononuclear Cells in the Cell-IQ System.

Uzhviyuk S, Khramtsov P, Raev M, Timganova V, Bochkova M, Khaziakhmatova O Bull Exp Biol Med. 2023; 175(1):172-178.

PMID: 37338769 DOI: 10.1007/s10517-023-05830-1.


Interaction of Graphene Oxide Nanoparticles with Human Mesenchymal Stem Cells Visualized in the Cell-IQ System.

Lazarev S, Uzhviyuk S, Rayev M, Timganova V, Bochkova M, Khaziakhmatova O Molecules. 2023; 28(10).

PMID: 37241889 PMC: 10222432. DOI: 10.3390/molecules28104148.


The Effect of PEGylated Graphene Oxide Nanoparticles on the Th17-Polarization of Activated T Helpers.

Zamorina S, Timganova V, Bochkova M, Shardina K, Uzhviyuk S, Khramtsov P Materials (Basel). 2023; 16(2).

PMID: 36676614 PMC: 9865146. DOI: 10.3390/ma16020877.


References
1.
Bianchi M, Allegri M, Chiu M, Costa A, Blosi M, Ortelli S . Lipopolysaccharide Adsorbed to the Bio-Corona of TiO Nanoparticles Powerfully Activates Selected Pro-inflammatory Transduction Pathways. Front Immunol. 2017; 8:866. PMC: 5540950. DOI: 10.3389/fimmu.2017.00866. View

2.
Schwarz H, Schmittner M, Duschl A, Horejs-Hoeck J . Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLoS One. 2014; 9(12):e113840. PMC: 4257590. DOI: 10.1371/journal.pone.0113840. View

3.
Achawi S, Pourchez J, Feneon B, Forest V . Graphene-Based Materials Toxicity and Their Structure-Activity Relationships: A Systematic Literature Review. Chem Res Toxicol. 2021; 34(9):2003-2018. DOI: 10.1021/acs.chemrestox.1c00243. View

4.
Chaudhri G, Clark I . Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J Immunol. 1989; 143(4):1290-4. View

5.
Cao W, He L, Cao W, Huang X, Jia K, Dai J . Recent progress of graphene oxide as a potential vaccine carrier and adjuvant. Acta Biomater. 2020; 112:14-28. DOI: 10.1016/j.actbio.2020.06.009. View